Vericel Corp Ord (VCEL)

Return on equity (ROE)

Dec 31, 2024 Sep 30, 2024 Jun 30, 2024 Mar 31, 2024 Dec 31, 2023 Sep 30, 2023 Jun 30, 2023 Mar 31, 2023 Dec 31, 2022 Sep 30, 2022 Jun 30, 2022 Mar 31, 2022 Dec 31, 2021 Sep 30, 2021 Jun 30, 2021 Mar 31, 2021 Dec 31, 2020 Sep 30, 2020 Jun 30, 2020 Mar 31, 2020
Net income (ttm) US$ in thousands 10,362 3,548 789 451 -2,024 -9,095 -12,012 -15,836 -16,408 -17,796 -16,150 -11,092 -7,472 214 8,763 4,280 2,864 145 -3 -11,526
Total stockholders’ equity US$ in thousands 291,967 257,472 242,977 233,896 225,952 204,380 198,928 193,978 192,272 177,837 174,816 172,485 170,462 156,780 151,092 140,209 134,260 114,630 107,596 110,452
ROE 3.55% 1.38% 0.32% 0.19% -0.90% -4.45% -6.04% -8.16% -8.53% -10.01% -9.24% -6.43% -4.38% 0.14% 5.80% 3.05% 2.13% 0.13% -0.00% -10.44%

December 31, 2024 calculation

ROE = Net income (ttm) ÷ Total stockholders’ equity
= $10,362K ÷ $291,967K
= 3.55%

Vericel Corp Ord's Return on Equity (ROE) experienced fluctuations over the period from March 31, 2020, to December 31, 2024. The company's ROE started at a negative figure of -10.44% in March 2020, indicating a loss on equity for the period. Throughout the following quarters, the ROE remained close to breakeven, reaching 0.13% by September 2020 and slightly increasing to 2.13% by December 2020.

In the subsequent quarters, Vericel Corp Ord's ROE demonstrated improvement, with significant increases recorded in March 2021 (3.05%) and June 2021 (5.80%). However, this positive trend was not sustained, as the ROE dropped to 0.14% by September 2021, followed by negative values in the subsequent quarters, reaching a low of -10.01% by September 2022.

Despite the fluctuations, there were periods of recovery in the company's ROE, such as the increase to 3.55% by December 2024. Overall, the analysis of Vericel Corp Ord's ROE highlights a volatile performance in generating returns on equity, indicating varying levels of profitability and efficiency in utilizing shareholder equity over the period analyzed.